KurierParty-alignedCenter6 hr. agoThe cost of health insurance coverage for medicinal treatments in Austria reached €4.9 billion in 2025, according to the first-ever Heilmittelreport published by the umbrella organization of social insurance providers. This represents a 7.5% increase compared to 2024 and an 88.2% rise since 2013. The report highlights that high-cost therapies and demographic changes are driving up expenses, with some medications costing up to €91,000 per package. While drug shortages have eased significantly, with alternatives available in most cases, Austria faces higher-than-average prices for patented medicines. The report emphasizes the need for equitable access to these advanced treatments, regardless of income.
Bias read (Center): The article presents factual data from the Heilmittelreport without overtly favoring any political stance. It discusses rising healthcare costs, factors contributing to them, and mentions both challenges and improvements in medication availability. There is no clear ideological framing or biased phr
ORF NewsState / PublicCenter9 hr. agoThe Austrian health insurance umbrella organization presented a report showing significant increases in costs for medical supply coverage, rising by 88.2 percent compared to 2013. The cost reached 4.9 billion euros in the previous year, with an additional 7.5 percent increase compared to 2024. On average, individuals who received at least one medication through health insurance incurred costs of around 800 euros, representing an 11 percent increase from 2024 and 86 percent from 2013. The main drivers were higher prices for prescriptions and demographic changes, as older insured individuals receive significantly more prescriptions annually. While the number of prescriptions decreased from 122 million in 2013 to 106 million in 2025, availability of medications improved, with nearly all cases having a substitute available. New drugs approved in Europe became available in Austria within 309 days on average, placing Austria third behind Germany and Italy in the EU. The number of pharmacies increased to 2,251, and the number of pharmaceutical companies listed in the reimbursement code (EKO) rose from 258 to 329.
Bias read (Center): The article presents factual data on healthcare costs and drug availability without overtly favoring any political stance. It reports on economic trends, demographic impacts, and institutional developments without clear ideological leaning. The framing remains balanced, focusing on statistical data,
Austria
